glp 1 stocks Betting on GLP-1 Boom in GLP-1 drugs augurs
Description
These statements have not been evaluated by the Food and Drug Administration
The booming class of GLP-1 drugs that includes Ozempic and Wegovy is also showing early potential to help with Parkinsons disease, a new study suggests.
Currently, only 11 states cover GLP-1s for weight loss under their state employee health plan, nine states provide coverage under their state Medicaid program, and five states provide coverage under both programs
PROMOTE HEALTHY FAT LOSS
Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity
Sustainable Tourism in Peru, Eco-friendly destinations, responsible accommodations and tips to minimize your impact on local communities.
